Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.
Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.
JTFM I actually bought into CRBP @ $1.80 , went over $11
Pulled back , settling here around $8 , next month or two will be interesting for this small Co, one drug three indications ,
Stock analyst have upside 12-20 bucks , might be something to look at ! JMHO
212K shares traded today and high up $4.50 closes up $2
On what ? Certainly not the volume !
We have entered into a Controlled Equity Offering SM Sales Agreement, or sales agreement, with Cantor Fitzgerald & Co. relating to shares of our common stock offered by this prospectus supplement and the accompanying prospectus. In accordance with the terms of the sales agreement, we may offer and sell shares of our common stock having an aggregate offering price of up to $35.0 million from time to time through Cantor Fitzgerald & Co. acting as sales agent.
Our common stock is listed on The NASDAQ Capital Market under the symbol “CRBP.” On November 22, 2016, the last reported sales price of our common stock on The NASDAQ Capital Market was $7.95 per share.
We are an “emerging growth company” as that term is used in the Jumpstart Our Business Startups Act of 2012 and, as such, we have elected to comply with certain reduced public company reporting requirements for this prospectus and may elect to comply with certain reduced public company reporting requirements for future filings.
Investing in our common stock involves risks. Before buying any shares, you should read the discussion of material risks of investing in our common stock in “ Risk Factors ” beginning on page S-6 of this prospectus supplement, on page 3 of the accompanying prospectus and in the documents incorporated by reference in this prospectus supplement.
Neither the Securities and Exchange Commission nor any state securities commission has approved or disapproved of these securities or determined if this prospectus is truthful or complete. Any representation to the contrary is a criminal offense.
Upon delivery of a placement notice, and subject to our instructions in that notice, and the terms and conditions of the sales agreement generally, Cantor Fitzgerald & Co. may sell our common stock by any method permitted by law deemed to be an “at the market offering” as defined by Rule 415(a)(4) promulgated under the Securities Act. Cantor Fitzgerald & Co. is not required to sell any specific number or dollar amount of securities, but will act as a sales agent using commercially reasonable efforts consistent with its normal trading and sales practices, on mutually agreed terms between Cantor Fitzgerald & Co. and us. There is no arrangement for funds to be received in any escrow, trust or similar arrangement.
Cantor Fitzgerald & Co. will be entitled to compensation at a fixed commission rate equal to 3% of the gross sales price per share sold. In connection with the sale of our common stock on our behalf, Cantor Fitzgerald & Co. will be deemed to be an “underwriter” within the meaning of the Securities Act and the compensation of Cantor Fitzgerald & Co. will be deemed to be underwriting commissions or discounts. See “Plan of Distribution” beginning on page S-13 for additional information regarding the compensation to be paid to Cantor Fitzgerald & Co.
JTFM , they are CIP s assuming they follow USPTO sim to Tech patent application s , North prob has much more knowledge than I do,
It's my understanding CIP s Claim priority date of parent application for the Benefit of " first to file "
Abandon applications may not necessarily mean abandoned , they can possibly be reactivated , but I think lose first to file
It's very confusing , we actually received our first patent last year for a tech patent ! I am sure Bio s are much more difficult to obtain. I am still holding in anticipation of the Corti drug launches and new guidance for 2017 - 2018
JMHO happy tg pal
Shorts did get burnt ! Pull back before launching forward for another heat wave !
Sounds like shorts took a hit yesterday
This election is creating allot of fear in market ! In my view , who ever takes WH is going to be faced with some of the biggest challenges the country has seen , debt being at top of list !
It's amazing seeing Pres campaign for Clinton , 8 years ago it was a slug fight ! Wonder what he would be saying about her if he could run for 3 Rd term, equally as interesting the establish Rep party is providing little support to Trump , so there's one thing in common here that stands out !!!!
Hopefully the market has a sense of humor Tuesday !
Jadite
I am with you , I can't see why large Pharm wouldn't want Libigel , it would certainly explain why ANI acquired Bpax ! It def wasn't for 18 mil in cash JMHO
3.1 Bil deal all cash for the patch ! Nice
Hope you are doing well
Anyone else see the 190k shares buy at close
Someone likes the price
Very impressive JTFM , you Sir are good ! The board is fortunate to have you here. Maybe after the elections moving into 2017 this will unfold !
Thanks pal
Any mention in his article why the FDA would grant a Fast track for their drug ? What motivated them ?
He did his job
Looks shady to me JMHO
Hi JTFM
Have you seen any news where ANI is with Corti drug & factories they are involved with in Europe , was it Ireland ?
I don't believe anything related to Corti is factored into the short term growth of this Co
Thanks 4 info
For the acquisition of Bpax to make ant sense @ all there has to be some sort of investment value in the deal , Art P is way to smart to give away part of ANI for 18 Mil in cash
Now it would make sense if there hasn't been such enormous gains in growing the Co in a relatively short period of time ! Could it have been bad judgement ? It's possible
But IMO I don't think so , & I don't think it was just Libi , or Gvax it was both. I am very pleased with the results our CEO has produced and very optimistic view of the near further. In summary besides the 18 Mil Bpax SH that have cost adv down and held are doing well.
All JMHO
Have a nice weekend
Thanks for the research JTFM
Best
BB i am sure he is used to being called worst
He's a miserable guy 4 sure always was
Iggy
42k buys @ 4 pm
Look @ SEC Filing Insiders options 8.71
Bullish !
JMHO
13 mil shares yes , 3.5 mil today
Price held up nicely !
Evening Dr Pete ,
This has been a great ride so far ! Our CEO has really done well for his investors , watching organic growth here and the success in such a short period of time is very impressive to see.
IMO next several months are going to be exciting
Hope you are doing !
Evening JTFM
I like the fact that Mr Art P is doing exactly what his said he would . " organic growth " to date it's been very impressive !
Nice 2 see this unfold , Corti launch will be something 2 C as well , IMO this is just getting started
Happy Friday !
I am optimistic that 2017 will deliver !
At some point have 2 move on, I married this 4 2 long
Best
Thanks JTFM it's been a long journey for some shareholders !
I go back to Cell Genesys so I am thinking 2017 will be my exit year here !
Hope all is well pal
Hi Jadite
I see ANIP had undisclosed market $ for anti infective drug
Any idea what est revenue is for it ?
Thanks
http://google.brand.edgar-online.com/displayfilinginfo.aspx?FilingID=11600330-1149-11150&type=sect&TabIndex=2&companyid=923762&ppu=%252fdefault.aspx%253fsym%253dCRBP
Option @ 7.14 50 K shares , IMO bullish
Insiders appear to be very confident !
JMHO
Yeah 275 K no movement in stock price !
Aprox 50k ah no stock movement lol
No Q They are no longer offering those share
Recent Price movement and insiders buying is bullish
anticipating pos results ? Could b a # of things
JMHO
ANIP prob one of the best performing stocks in biotech sector ! It's rare to have had the opportunity to buy / sell this Co , look toward projected forward earnings , especially 3 & 4 th Q
Those smart enough to have traded this did well. Unfortunately the economic climate is rocky , the swings we are seeing are IMO are consistent with most stocks
JMHO
JTFM
This CEO is a very capable guy ! I had my concerns a couple years ago, Art P has done a excellent job in growing revenue s
Organic growth ! I really think revenues will keep jumping Q2Q
Best
Looks like the bank wanted blood ! And got it
I read the non final , all claims were rejected !
Hi JTFM
I could be wrong but this looks like a revolving credit line , 30 mil for a Co in line to do 120 mil in sales seems in line
They maybe using some money for expansion. , revolving credit float bills , payroll while money is coming in. Sounds like this co is growing rapidly
Best
JTFM
Earning guidance was set 119-134 mil 2016 IMO assuming they hit mid the PPS should be 80-90
In good market 100+
Since they did launch some additional drugs , I can see them raising it to 150mil that's with no surprises !
2017 170-200 mil is a good guess again very conservative ,
Too many wild cards here , factories in Europe new drugs recently acquired is anyone's guess ,
Very promising JMHO
Hi Jadite ,
Poss earning next month , launching 8 products , new coverage by Raymond James , 65 price targets ,
I would not be surprised if the raise earning guidance 2
Best
Looks like another large buy @ close 48 k share
Over 2 1/2 mil bucks
JTFM
Any idea what this will generate in revenue , and was it included in 2016 guidance ?
Thank You
Sry UE
JTFM
We not only held up well, 18 K buy at close !
Recent attacks here and abroad appears to have had a impact on their voting to leave UK, Trumps message is resonating.
Let's hope the markets hold up for rest of year, today was a good indication it will ! The market showed strength.
JMHO
Nice 18k @ close
Held up nicely today considering market reaction to Brits finally waking up !!! Great move
Trumps was right yet again !